- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07943117
Videocapillaroscopic Findings in Hand Osteoarthritis
Association of Nailfold Videocapillaroscopy Findings With Clinical, Functional, and Radiological Characteristics in Primary Hand Osteoarthritis: A Comparative Cross-Sectional Study With Healthy Controls
The purpose of this study is to compare microvascular changes-assessed via nailfold videocapillaroscopy-in patients with primary hand osteoarthritis against a healthy control group, and to investigate the relationship between capillaroscopic findings and disease severity, functional status, and clinical characteristics.
Study Overview
Status
Conditions
Detailed Description
In this context, the associations between capillaroscopic parameters and the Kellgren-Lawrence radiological grading, handgrip strength, the Functional Index for Hand Osteoarthritis (FIHOA), and the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) scores will be evaluated. Furthermore, the study aims to determine the potential clinical value of nailfold videocapillaroscopy in identifying microvascular alterations associated with primary hand osteoarthritis.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Nurten NAS KIRDAR, Assistant Professor
- Phone Number: +905415511691
- Email: nkirdar@bandirma.edu.tr
Study Contact Backup
- Name: Ayşegül ÖZDOĞAN BİRCAN, Specialist Physician
Study Locations
-
-
Balıkesir
-
Bandırma, Balıkesir, Turkey (Türkiye), 10200
- Bandırma Onyedi Eylul University Faculty of Medicine
-
Contact:
- Ayşe Güldem Kilciler, Prof.
- Phone Number: +9 0266 717 01 17
- Email: akilciler@bandirma.edu.tr
-
Contact:
- Ayşegül ÖZDOĞAN BİRCAN, Specialist physician
- Email: aysegll_87@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The study population will consist of patients diagnosed with primary hand osteoarthritis and age- and sex-matched healthy controls. Participants will undergo clinical assessment, hand function evaluation, radiographic assessment, and nailfold videocapillaroscopy.
Description
Inclusion Criteria:
-
Patient group (Primary hand osteoarthritis)
- Being 18 years of age or older.
- Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
- Being willing to participate in the study and having signed the written Informed Consent Form.
- Being able to undergo clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
- Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.
Healthy control group
- Being 18 years of age or older.
- Having no diagnosis of inflammatory rheumatologic disease or primary hand osteoarthritis.
- Being willing to participate in the study and having signed the written Informed Consent Form.
- Being similar to the patient group in terms of age and gender.
- Being able to undergo nailfold videocapillaroscopy assessment.
Exclusion Criteria:
-
Patient group
- Being under 18 years of age.
- Diagnosis of secondary osteoarthritis of the hand (due to trauma, infection, metabolic, or other causes).
- Presence of rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, inflammatory myopathies, vasculitis, or other connective tissue diseases.
- History of Raynaud's phenomenon.
- History of malignancy.
- Chronic renal failure (stage 4-5) or advanced liver failure.
- Active infection or a serious infection within the last four weeks.
- Pregnancy or breastfeeding.
- History of a neurological condition that could affect hand grip strength (e.g., hemiplegia, tetraplegia, peripheral nerve injury, or other neurological/neuromuscular disorders resulting in loss of muscle strength).
- History of trauma, surgical intervention, or any procedure affecting the nail bed of the fingers within the last month.
- Presence of an open wound, active infection, severe dermatological condition, or deformity that would hinder the assessment of the nail fold.
- Refusal to participate in the study or failure to sign the informed consent form.
Healthy control group
In addition to the exclusion criteria listed above:
- Diagnosis of primary osteoarthritis of the hand or any inflammatory rheumatic disease.
- Presence of hand pain or any chronic musculoskeletal disorder that affects hand function.
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_CONTROL
- Time Perspectives: CROSS_SECTIONAL
Cohorts and Interventions
Group / Cohort |
|---|
|
hand osteoarthritis group
hand osteoarthritis group;
|
|
control group
control group;
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nailfold videocapillaroscopic microvascular parameters
Time Frame: 6 months
|
The primary outcome is the comparison of nailfold videocapillaroscopic microvascular parameters between patients with primary hand osteoarthritis and healthy controls. Nailfold videocapillaroscopy will be performed using the Dino-Lite Capillary Scope Pro200 digital microscope and DinoCapture v2.0 software. Prior to the examination, participants will be required to rest for at least 15 minutes in a room maintained at a constant temperature of 20-22°C; they will also be instructed to refrain from smoking or consuming caffeine for at least 30 minutes before the procedure. Participants will be questioned regarding any recent manicures, nail-biting, local trauma, or other procedures that might affect the nail bed. During the examination, the hands will be kept at the level of the heart, and immersion oil will be applied to the nailfold. The second through fifth digits of both hands will be evaluated at ×200 magnification, and images of two 1 mm areas from each digit will be recorded. |
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kellgren-Lawrence classification
Time Frame: 6 months
|
Participants' hand radiographs will be evaluated for signs of osteoarthritis. The presence of osteophytes, joint space narrowing, subchondral sclerosis, cystic changes, and deformities in the distal interphalangeal, proximal interphalangeal, and first carpometacarpal joints will be recorded. The radiological severity of the disease will be graded from 0 to 4 for each joint using the Kellgren-Lawrence classification: grade 0, no radiological evidence of osteoarthritis; grade 1, questionable joint space narrowing and possible osteophytes; grade 2, definite osteophytes and possible joint space narrowing; grade 3, multiple osteophytes, definite joint space narrowing, sclerosis, and possible bone contour deformity; and grade 4, severe joint space loss, large osteophytes, marked sclerosis, and bone deformity. Radiographic hand osteoarthritis will be defined, in general, as a Kellgren-Lawrence grade of ≥2. |
6 months
|
|
Australian/Canadian Osteoarthritis Hand Index (AUSCAN)
Time Frame: 6 months
|
Disease-related pain, stiffness, and functional impairment will be assessed using the Australian/Canadian Osteoarthritis Hand Index (AUSCAN). AUSCAN is a 15-item, patient-reported outcome measure developed for hand osteoarthritis, comprising subscales for pain (5 items), morning stiffness (1 item), and physical function (9 items). The function subscale evaluates difficulty with activities of daily living, such as turning on a faucet, operating a doorknob, buttoning clothes, opening a jar, carrying heavy objects, and grasping small items. The scale can be administered using Likert, visual analog, or numerical rating formats; the specific version and scoring method to be used in this study will be standardized in advance. Higher scores indicate more severe symptoms and greater loss of function. |
6 months
|
|
Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index)
Time Frame: 6 months
|
Functional impairment due to hand osteoarthritis will also be assessed using the Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index). The FIHOA is a 10-item scale that evaluates daily hand functions, such as using a key, cutting with a knife, opening a bottle or jar, buttoning, writing, lifting objects, and shaking hands. Each item is scored on a scale of 0-3, with a total score ranging from 0-30; a higher score indicates greater functional impairment. The validity and reliability of the Turkish version of the FIHOA have been established, and it has been reported to demonstrate high internal consistency and test-retest reliability. |
6 months
|
|
Handgrip strength
Time Frame: 6 months
|
Grip strength will be measured separately for each hand using a standard hand dynamometer (Baseline brand, 200 lb LITE hydraulic hand dynamometer). During the measurement, the participant will be in a seated position, with the shoulder in adduction and neutral rotation, the elbow flexed at approximately 90°, the forearm in a neutral position, and the wrist in slight extension. Three measurements will be taken for each hand, with short rest intervals between them; the analysis will utilize either the mean of these measurements or the highest value, in accordance with a pre-established protocol. The brand and model of the dynamometer used will be specified in the research form. Grip strength measurements obtained via a hand dynamometer have been shown to be reliable in patients with hand osteoarthritis. |
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-67961857-050.04-2600065387
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data (IPD) will not be shared with other researchers due to patient confidentiality and data privacy considerations. Only anonymized aggregate data may be reported in the publication.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.